This is unpublished

OKRA/KOAR

Active Studies
Transplantation
Pinned
Principal Investigator
Nicolae Leca, MD
Funding Agency
Sponsor: CareDx, Inc.
Status
Active
Enrollment closed

Investigator

Nicolae Leca, MD

 

 

 

Nicolae Leca, MD

 

 

What is the What is the OKRA/KOAR Study?

Evaluation of Patient Outcomes from the Kidney Allograft Outcomes Allosure Registry -- The primary efficacy objective is to test the hypothesis that a strategy of monitoring for rejection that introduces AlloSure into clinical practice does not lead to inferior renal allograft outcomes when compared to a strategy of monitoring for rejection that does not include AlloSure. 

What are the criteria for the study?

Single de-novo or repeat renal transplant recipients selected to receive AlloSure testing as part of their routine care beginning within 2 months post-transplant

WHO DO I CONTACT FOR MORE INFORMATION?

Research Coordinator

Belinda Pan
E: bcpan@uw.edu